Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease

• Patricia A. Jorquera,

  Affiliation Department of Infectious Disease, University of Georgia, Athens, Georgia, United States of America

  ⨯
• Youngjoo Choi,

  Affiliation Department of Infectious Disease, University of Georgia, Athens, Georgia, United States of America

  ⨯
• Katie E. Oakley,

  Affiliation Department of Infectious Disease, University of Georgia, Athens, Georgia, United States of America

  ⨯
• Thomas J. Powell,

  Affiliation Artificial Cell Technologies, New Haven, Connecticut, United States of America

  ⨯
• James G. Boyd,

  Affiliation Artificial Cell Technologies, New Haven, Connecticut, United States of America

  ⨯
• Naveen Palath,

  Affiliation Artificial Cell Technologies, New Haven, Connecticut, United States of America

  ⨯
• Lia M. Haynes,

  Affiliation Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Larry J. Anderson,

  Affiliation Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Ralph A. Tripp

  * E-mail: ratripp@uga.edu

  Affiliation Department of Infectious Disease, University of Georgia, Athens, Georgia, United States of America

  ⨯